v3.25.1
Condensed Interim Consolidated Statements of Changes in Shareholders' (Deficiency) Equity (Unaudited) - CAD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2023 $ 31,516 $ 116,069,973 $ (104,566,816) $ (1,788,987) $ 9,745,686
Balance, shares at Dec. 31, 2023 149,300,920          
Net loss for the period   (9,347,180) (9,347,180)
Share-based compensation   389,612 389,612
Exchange differences on translation of foreign operations   (137,237) (137,237)
Exercise of options, net  
Exercise of options, net, shares 126,259          
Balance at Mar. 31, 2024 31,516 116,459,585 (113,913,996) (1,926,224) 650,881
Balance, shares at Mar. 31, 2024 149,427,179          
Balance at Dec. 31, 2023 31,516 116,069,973 (104,566,816) (1,788,987) $ 9,745,686
Balance, shares at Dec. 31, 2023 149,300,920          
Exercise of options, net, shares 126,259         278,100
Balance at Dec. 31, 2024 31,516 145,025,333 (146,987,099) (1,516,810) $ (3,447,060)
Balance, shares at Dec. 31, 2024 185,708,588          
Net loss for the period   (15,228,330) (15,228,330)
Share capital issued through private placement   49,709,891 49,709,891
Share capital issued through private placement, shares 167,899,061          
Share issue costs – private placement   (5,389,306) (5,389,306)
Share capital issued through debt conversion   26,594,817 26,594,817
Share capital issued through debt conversion, shares 75,378,825          
Share issue costs – debt conversion   (2,161,483) (2,161,483)
Share-based compensation   1,027,581 1,027,581
Exchange differences on translation of foreign operations   479,748 479,748
Balance at Mar. 31, 2025 $ 31,516 $ 214,806,833 $ (162,215,429) $ (1,037,062) $ 51,585,858
Balance, shares at Mar. 31, 2025 428,986,474